F2 and blood coagulation disease: COVID-19-related coagulopathy shares similarities with diffuse intravascular coagulation, being associated with increased fibrinolytic activity (and raised D-dimer concentrations), slightly prolonged prothrombin time and reduced platelet counts [27].